For patients with intermediate or lower risk essential thrombocythemia with plt >1000 but no symptoms, do you favor aspirin only therapy or aspirin and cytoreduction?
Recent data without increased cumulative incidence of bleeding in ET patients with plt >1000. Has your practice changed to use cytoreduction less frequently? Have your frequency for monitoring for acquired vWD changed?
Community PollStarted
How do you treat non-high risk ET patients with plt >1000?
18 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Hematology · Johns Hopkins University
Answered on
First, the wrong question is being asked. The correct question is, what is the proof that the low-risk, intermediate-risk, or high-risk ET classification has any validity? My answer would be that this classification has no validity. Whether it is based on the IPSET scoring system or one of the other...
Join for free or sign in to see the full answer